Clinical Trials in Delaware
Here are the 6 most popular medical studies in Delaware Clinical Trials
CAR T-cell Therapy
FT576 for Multiple Myeloma
Recruiting1 awardPhase 1
Newark, Delaware
This trial is testing a new drug, FT576, for multiple myeloma (MM). The study will have two parts: a dose-escalation stage, where patients receive different doses of FT576 to find the best one, and an expansion stage, where patients receive FT576 in combination with daratumumab.
PARP Inhibitor
Pembrolizumab + Olaparib for Pancreatic Cancer
Recruiting1 awardPhase 2
Norwalk, Connecticut
This trial is testing whether adding pembrolizumab to olaparib, which is the standard of care, is more effective in treating patients with metastatic pancreatic cancer who have BRCA1 or BRCA2 mutations.
Popular filter options for Delaware Clinical Trials trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Hormone Therapy
Less Intense Treatment for Unfavorable Intermediate Risk Prostate Cancer with Low Gene Risk Score and More Intense Treatment for Unfavorable Intermediate Risk Prostate Cancer with High Gene Risk Score
Recruiting2 awardsPhase 3
Frankford, Delaware
This trial is testing whether using the Decipher risk score to guide treatment results in better control of the cancer and prevents it from spreading, with fewer side effects.
Radiation Therapy
High Dose Radiation vs Whole Brain Radiation for Brain Metastasis
Recruiting2 awardsPhase 3
Salisbury, Maryland
This trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus for the treatment of small cell lung cancer that has spread to the brain.
Checkpoint Inhibitor
Immunotherapy with Nivolumab and Ipilimumab followed by Nivolumab or Nivolumab with Cabozantinib for Kidney Cancer
Recruiting2 awardsPhase 3
Frankford, Delaware
This trial is testing a new combination treatment for patients with untreated renal cell carcinoma. The usual treatment is immunotherapy with ipilimumab and nivolumab, followed by nivolumab alone. The new treatment adds cabozantinib to nivolumab after initial treatment with ipilimumab and nivolumab. It is not yet known if this new combination treatment is better than the usual treatment.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Hormone Therapy
Less Intense Treatment for Unfavorable Intermediate Risk Prostate Cancer with Low Gene Risk Score and More Intense Treatment for Unfavorable Intermediate Risk Prostate Cancer with High Gene Risk Score
Recruiting2 awardsPhase 3
Frankford, Delaware
This trial is testing whether using the Decipher risk score to guide treatment results in better control of the cancer and prevents it from spreading, with fewer side effects.
Radiation Therapy
High Dose Radiation vs Whole Brain Radiation for Brain Metastasis
Recruiting2 awardsPhase 3
Salisbury, Maryland
This trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus for the treatment of small cell lung cancer that has spread to the brain.
IDH2 Inhibitor
Enasidenib for Acute Myeloid Leukemia
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing the side effects of enasidenib and how well it works in treating patients with acute myeloid leukemia that has come back after treatment or has been difficult to treat with chemotherapy.
Behavioural Intervention
Survivorship Care Planning for Prostate Cancer
Recruiting1 award15 criteria
Rehoboth Beach, Delaware
This trial is testing whether increasing the coordination of care between the cancer care team and the primary care team improves care and outcomes for prostate cancer survivors.
View More Delaware Clinical Trials Trials
See another 84 many medical studies focused on Delaware Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.